scholarly journals Attitudinal Factors Associated with Prostate Cancer among Adult Males in South Eastern Nigeria

2017 ◽  
Vol 2 (2) ◽  
pp. 147
Author(s):  
Nnaemeka C. Abamara ◽  
Leonard N. Ezeh ◽  
Nkechi N. Anazodo ◽  
Cynthia N. Onyejiaka

<p><em>Prostate cancer is one of the most common and lethal cancers in the world. The incidence of prostate cancer has been increasing in recent years. Beliefs and awareness towards prostate cancer screening among men is very crucial for early detection and management of the condition. In Nigeria, it is the most common male cancer and maybe as high as that seen in African Americans in the united states. This paper examines the knowledge, belief and attitudes of men in Nigeria towards prostate cancer and prostate cancer screening for the peaceful existence in our society</em><em>.</em></p>

Urology ◽  
2021 ◽  
Author(s):  
Rand N. Wilcox Vanden Berg ◽  
Spyridon P. Basourakos ◽  
Jonathan Shoag ◽  
Douglas Scherr ◽  
Bashir Al Hussein Al Awamlh

Urology ◽  
2016 ◽  
Vol 97 ◽  
pp. 111-117 ◽  
Author(s):  
Simon P. Kim ◽  
R. Jeffrey Karnes ◽  
Cary P. Gross ◽  
Neal J. Meropol ◽  
Holly Van Houten ◽  
...  

2011 ◽  
Vol 29 (13) ◽  
pp. 1736-1743 ◽  
Author(s):  
Michael W. Drazer ◽  
Dezheng Huo ◽  
Mara A. Schonberg ◽  
Aria Razmaria ◽  
Scott E. Eggener

Purpose For patients who elect to have prostate cancer screening, the optimal time to discontinue screening is unknown. Our objective was to describe rates and predictors of prostate-specific antigen (PSA) screening among older men in the United States. Methods Data were extracted from the population-based 2000 and 2005 National Health Interview Survey (NHIS). PSA screening was defined as a PSA test as part of a routine exam within the past year. Demographic, socioeconomic, and functional characteristics were collected, and a validated 5-year estimated life expectancy was calculated. Age-specific rates of PSA screening were determined, and sampling weight-adjusted multivariate regressions were fitted to determine predictors of screening among men age 70 years or older. Results The PSA screening rate was 24.0% in men age 50 to 54 years, and it increased steadily with age until a peak of 45.5% among age 70 to 74 years. Screening rates then gradually declined by age, and 24.6% of men age 85 years or older reported being screened. Among men age 70 years or older, screening rates varied by estimated 5-year life expectancy: rates were 47.3% in men with high life expectancies (≤ 15% probability of 5-year mortality), 39.2% in men with intermediate life expectancies (16% to 48% probability), and 30.7% in men with low life expectancies (> 48% probability; P < .001). In multivariate analysis, estimated life expectancy and age remained independently associated with PSA screening (P < .001 for each). Conclusion Rates of PSA screening in the United States are associated with age and estimated life expectancy, but excessive PSA screening in elderly men with limited life expectancies remains a significant problem. The merits and limitations of PSA should be discussed with all patients considering prostate cancer screening.


2006 ◽  
Vol 175 (4S) ◽  
pp. 155-155
Author(s):  
Charles D. Scales ◽  
Lesley H. Curtis ◽  
Regina D. Norris ◽  
Kevin A. Schulman ◽  
Philipp Dahm ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document